CTRI/2019/12/022451已完成未知
Efficacy of combination of midodrine with propranolol in preventing first bleed in decompensated cirrhotics with severe ascites. A randomized controlled trial.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Decompensated Child C cirrhotics with grade II-III requiring primary prophylaxis
排除标准
- •1) Spontaneous bacterial peritonitis
- •2) Hepatic Encephalopathy
- •3) Acute renal failure (S.Cr >1.5)
- •4) Hepatorenal syndrome
- •5) Hypertension
- •6) Coronary Artery Disease ; H/o arrhythmias, heart block
- •7) Urinary retention
- •8) Pheochromocytoma/thyrotoxicosis
- •9) Coronary Obstructive Pulmonary Disease
- •10) Hepatocellular Carcinoma
- •11) Pregnancy
- •12) Portal vein Thrombosis
研究者
相似试验
招募中
不适用
To Study Effect of the Combination of Midodrine and Tolvaptan (drug) Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis (Liver Disease).CTRI/2021/09/036265Institute of Liver and Biliary Sciences
已完成
3 期
oradrenalin versus Midodrin-Octerotid in Hepatorenal SyndromeHepatorenal Syndrome type 1 & 2.Hepatorenal SyndromeIRCT201107217085N1Vice Chancellery for Reserch and Technology, Isfahan University of Medical Sciences, Isfahan, Iran22
暂停
不适用
Efficacy and safety of midodrine in refractory or recurrent ascites in children with cirrhosisCTRI/2021/12/038602ILBS
尚未招募
Unknown
Midodrine plus albumin for ascites controlCTRI/2023/05/052752Mylan Pharmaceuticals Pvt Ltd
招募中
3 期
Investigating the effect of midodrine in preventing septic shock in childrePreventing septic shock in children with severe sepsis.Severe sepsis without septic shockR65.20IRCT20120520009801N14Mashhad University of Medical Sciences70